BNIP-3 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of BNIP-3 monoclonal antibodies for research focused on understanding BNIP-3's role in cellular processes. Multiple detection methods are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BNIP-3, or Bcl-2/adenovirus E1B 19 kDa interacting protein 3, is a pro-apoptotic protein that plays a crucial role in regulating cell death and survival, particularly in response to hypoxic conditions. BNIP-3 influences mitochondrial function and has been linked to various pathological conditions, including cancer and neurodegenerative diseases. Research into BNIP-3 function continues to reveal its potential as a therapeutic target. Scientists worldwide use BNIP-3 monoclonal antibodies to advance their understanding of cell death mechanisms and disease pathways. Ongoing studies of BNIP-3 contribute to the development of new therapeutic strategies for various diseases. Santa Cruz Biotechnology monoclonal antibodies for BNIP-3 enable researchers to make meaningful contributions to scientific knowledge and potential therapeutic applications.